Qualifying Therapeutic Discovery Project Grants for the State of Kansas
The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.
The project descriptions below were extracted from the applicant certification forms as submitted.
| Applicant Name | Project Name | Grants Awarded for 2009 | Grants Awarded for 2010 |
|---|---|---|---|
| CritiTech, Inc | Nanotax®: sustained drug release from pure drug nanoparticles to treat ovarian cancer | $ 150,954.50 | $ 93,524.74 |
| CritiTech, Inc. | Nanothecin™: sustained drug release from pure drug nanoparticles to treat peritoneal cancer | $ 133,544.50 | $ 110,934.74 |
| CyDex Pharmaceuticals Inc | Melphalan HC1 for Injection(Propylene Glycol Free) | $ 244,479.24 | |
| CyDex Pharmaceuticals Inc | New Dosage Form of Clopidogrel-Rapid Onset Injectable | $ 133,059.00 | $ 111,420.24 |
| Edenspace Systems Corporation | An oral Therapeutic Agent for Ischemic, Inflammatory and Immune Disorders | $ 3,316.00 | $ 68,826.00 |
| ImmunoGenetix Therapeutics, Inc | GeneProTM (4SHIVku2)- a DNA vaccine therapeutic for HIV patients | $ 57,552.08 | $ 15,420.00 |
| KC BioMedix, Inc | Ntrainer System ® | $ 244,479.24 | |
| Madeira Therapeutics LLC | Novel Analgesic Oral Solution to Treat Pain in Children. | $ 154,500.00 | |
| Maderia Therapeutics, LLC | Novel Simvastatian Oral Solution to Treat High Cholesterol in Children | $ 198,050.00 | $ 46,429.24 |
| NanoScale Corporation | Functionalized Core/Shell Fe/Fe304 Stealth Nanoparticles for Cancer Diagnosis & Treatment | $ 78,000.00 | |
| NanoScale Corporation | Intelligent Low-Toxicity Materials for Cancer Diagnosis and Treatment. | $ 66,869.00 | $ 54,807.46 |
| Nexus Medical, LLC | Nexus TKO | $ 187,678.50 | $ 56,800.75 |
| Oncimmune (USA) LLC | EarlyCDT-Lung-a novel blood test to aid in the early detection of cancer | $ 244,479.24 | |
| Orbis Biosciences, Inc | Precision Particle Fabrication Technology for improving Therapeutics through API Control | $ 149,637.14 | $ 94,842.10 |
| Pulse NeedleFree Systems, Inc. | Multi-Use Needle-Free Injection Device | $ 53,817.50 | $ 86,917.50 |
| Spinal Simplicity, LLC | Minuteman & Scarab Interspinous Process Fusion Cage Devices | $ 120,187.78 | $ 124,291.47 |
| TVAX Biomedical, LLC | TVI-Brain-1 as a Treatment for Malignant Cancer | $ 9,183.50 | $ 235,295.74 |
| VasoGenix Pharmaceuticals Inc | Novel Sustained Treatment of Heart Failure | $ 244,479.24 | |
| Verrow Pharmaceuticals Inc | Development of a new kidney protective x-ray contrast dye | $ 235,199.50 | $ 9,279.74 |
References/Related Topics
Page Last Reviewed or Updated: 2012-10-12
